Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HC106 in Female Urinary Incontinence
NCT06738576Phase 1Recruiting
- Sponsor
- Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
- Start
- Dec 2024
- Primary completion
- Mar 2027
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1 trial of HC106 in stress urinary incontinence (SUI) (2 arms), sponsored by Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz. Primary endpoint: Proportion of patients with at least one of the complications derived from the treatment at 7 days. Started Dec 2024; status: recruiting.
02
Drugs
HC106
03
Conditions
stress urinary incontinence (SUI)
Beyond the preview
Go deeper on NCT06738576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06738576.